Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors

被引:548
作者
Arai, F
Miyamoto, T
Ohneda, O
Inada, T
Sudo, T
Brasel, K
Miyata, T
Anderson, DM
Suda, T
机构
[1] Kumamoto Univ, Sch Med, IMEG, Dept Cell Differentiat, Kumamoto 8600811, Japan
[2] Meikai Univ, Sch Dent, Dept Periodontol, Sakado, Saitama 3500248, Japan
[3] Toray Industries Ltd, Basic Res Labs, Kamakura, Kanagawa 2480036, Japan
[4] Immunex Res & Dev Corp, Dept Mol Biol, Seattle, WA 98101 USA
关键词
osteoclastogenesis; commitment; macrophage; RANK ligand; M-CSF;
D O I
10.1084/jem.190.12.1741
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteoclasts are terminally differentiated cells derived from hematopoietic stem cells. However, how their precursor cells diverge from macrophagic lineages is not known. We have identified early and late stages of osteoclastogenesis, in which precursor cells sequentially express c-Fms followed by receptor activator of nuclear factor kappa B (RANK), and have demonstrated that RANK expression in early-stage of precursor cells (c-Fms(+)RANK(-)) was stimulated by macrophage colony-stimulating factor (M-CSF). Although M-CSF and RANKL (ligand) induced commitment of late-stage precursor cells (c-Fms(+)RANK(+)) into osteoclasts, even late-stage precursors have the potential to differentiate into macrophages without RANKL. Pretreatment of precursors with M-CSF and delayed addition of RANKL showed that timing of RANK expression and subsequent binding of RANKL are critical for osteoclastogenesis. Thus, the RANK-RANKL system determines the osteoclast differentiation of bipotential precursors in the default pathway of macrophage differentiation.
引用
收藏
页码:1741 / 1754
页数:14
相关论文
共 52 条
  • [1] A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
    Anderson, DM
    Maraskovsky, E
    Billingsley, WL
    Dougall, WC
    Tometsko, ME
    Roux, ER
    Teepe, MC
    DuBose, RF
    Cosman, D
    Galibert, L
    [J]. NATURE, 1997, 390 (6656) : 175 - 179
  • [2] OSTEOCLASTS DERIVED FROM HEMATOPOIETIC STEM-CELLS
    ASH, P
    LOUTIT, JF
    TOWNSEND, KMS
    [J]. NATURE, 1980, 283 (5748) : 669 - 670
  • [3] DELAYED HEMATOPOIETIC DEVELOPMENT IN OSTEOPETROTIC (OP/OP) MICE
    BEGG, SK
    RADLEY, JM
    POLLARD, JW
    CHISHOLM, OT
    STANLEY, ER
    BERTONCELLO, I
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (01) : 237 - 242
  • [4] BEGG SK, 1993, EXP HEMATOL, V21, P493
  • [5] Requirement for NF-κB in osteoclast and B-cell development
    Franzoso, G
    Carlson, L
    Xing, LP
    Poljak, L
    Shores, EW
    Brown, KD
    Leonardi, A
    Tran, T
    Boyce, BF
    Siebenlist, U
    [J]. GENES & DEVELOPMENT, 1997, 11 (24) : 3482 - 3496
  • [6] TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
    Fuller, K
    Wong, B
    Fox, S
    Choi, YW
    Chambers, TJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) : 997 - 1001
  • [7] The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-κB, a member of the TNFR superfamily
    Galibert, L
    Tometsko, ME
    Anderson, DM
    Cosman, D
    Dougall, WC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) : 34120 - 34127
  • [8] C-FOS - A KEY REGULATOR OF OSTEOCLAST-MACROPHAGE LINEAGE DETERMINATION AND BONE REMODELING
    GRIGORIADIS, AE
    WANG, ZQ
    CECCHINI, MG
    HOFSTETTER, W
    FELIX, R
    FLEISCH, HA
    WAGNER, EF
    [J]. SCIENCE, 1994, 266 (5184) : 443 - 448
  • [9] Hayashi S, 1997, J CELL PHYSIOL, V170, P241, DOI 10.1002/(SICI)1097-4652(199703)170:3<241::AID-JCP4>3.0.CO
  • [10] 2-O